Mabwell, a cutting-edge biopharmaceutical company with full industry integration, revealed that its new Nectin-4 focused ADC (R&D code: 9MW2821) has been given the green light by the NMPA to move into phase II clinical testing as a standalone...
CordenPharma, a partner for CDMO services for biotech and pharma companies developing complex modalities, has revealed its most significant strategic investment of approximately €900 million in the next three years to expand its peptide technology...
Mankind Pharma announced that it has signed a non-exclusive patent licensing deal with Takeda, a Japanese pharmaceutical company, to distribute Takeda's drug Vonoprazan in India. Mankind Pharma announced that it has signed a non-exclusive patent...
A new "high efficacy" malaria vaccine co-created by the Serum Institute of India (SII) and the University of Oxford was formally carried out on Monday when Cote d'Ivoire in West Africa turned into the initial nation to commence regulating...
The IMA recently revealed a new booklet named 'Headache Algorithm: A guide to Headache Management' which focuses on managing headache disorders in India. This effort arrives at a critical moment as headache control is the primary reason for...
In order to expedite research on new remedies for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., a global leader in serving science, is teaming up with the National Cancer Institute (NCI)...
Inspira Technologies, an innovative medical technology firm, has revealed that the INSPIRA ART100, an extracorporeal membrane oxygenation and cardiopulmonary bypass system, has been granted approval by the Israeli Ministry of Health for medical...
Medical, Inc., an innovative biopharmaceutical business developing unique, long-term medication implants, said that the first clinical study in the NPM-115 program is expected to begin in Australia in the fourth quarter of 2024, subject to...
The National Medical Products Administration of China has approved CSPC Pharmaceutical Group's respiratory syncytial virus (RSV) vaccine candidate for human clinical trials, the company announced. RSV, which causes symptoms similar to a cold but...
The Swedish biopharma company BioArctic AB announced that its partner Eisai has been granted approval by the Department of Health in Hong Kong for the treatment of Alzheimer's disease with Leqembi. Patients who are in the mild cognitive impairment...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
